JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats

British Journal of Pharmacology

Volumn 126, Issue 7, 1999, Pages 1674-1680

  Ohta, Takeshi ^a   Furukawa, Noboru ^a   Komuro, Goro ^a   Yonemori, Fumihiko ^a   Wakitani, Korekiyo ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Antidiabetic agent; GK rat; Insulin secretion; JTT 608; Perfused pancreas

Indexed keywords

4 (4 METHYLCYCLOHEXYL) 4 OXOBUTYRIC ACID; ANTIDIABETIC AGENT; GLUCOSE; INSULIN; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE TEST; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0032907568     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702481     Document Type: Article

References (34)

1. AGARDH, C.-D., AGARDH, E., ZHANG, H. & ÖSTENSON, C.-G. (1997). Altered endothelial/pericyte ratio in Goto-Kakizaki rat retina. J. Diab. Comp., 11, 158-162.
2. ASPLUND, K., WIHOLM, B.E. & LITHNER, F. (1983). Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia, 24, 412-417.
3. BRUNZELL, J.D., ROBERTSON, R.P., LERNER, R.L., HAZZARD, W.R., ENSINCK, J.W., BIERMAN, E.L. & PORTE, D. (1976). Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J. Clin. Endocrinol. Metab., 42, 222-229.
4. CERASI, E., LUFT, R. & EFENDIC, S. (1972). Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. Diabetes, 21, 224-234.
5. FERNER, R.E. & NEIL, H.A.W. (1988). Sulphonylureas and hypoglycaemia. Br. Med. J., 296, 949-950.
6. FUJITANI, S., IKENOUE, T., AKIYOSHI, M., MAKI, T. & YADA, T. (1996). Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-41566, in perfused rat pancreas. Metabolism, 45, 184-189.
7. GERICH, J.E. (1989). Oral hypolgycemic agents. N. Engl. J. Med., 321, 1231-1245.
8. GOTO, Y., SUZUKI, K.I., SASAKI, M., ONO, T. & ABE, S. (1988). GK rat as a model of non-obese non-insulin-dependent diabetes: selective breeding over 35 generations. In Frontiers of Diabetes Research. Lesson from Animal Diabetee II. eds. Shafrir, E. & Reynold, A.E. pp. 301-303. London: Libbey.
9. GRODSKY, G.M., EPSTEIN, G.H., FANSKA, R. & KARAM, J.H. (1977). Pancreatic action of the sulfonylureas. Fed. Proc., 36, 2714-2719.
10. GRODSKY, G.M. & FANSKA, R.E. (1975). The in vitro perfused pancreas. Methods Enzymol., 39, 364-372.
11. GROOP, L.C. (1992). Sulfonylureas in NIDDM. Diabetes Care, 15, 737-754.
12. JACKSON, J.E. & BRESSLER, R. (1981). Clinical pharmacology of sulphonylurea hypoglycaemic agents: part I. Drugs, 22, 211-245.
13. KIMURA, K., TOYOTA, T., KAKIZAKI, M., KUDO, M., TAKEBE, K. & GOTO, Y. (1982). Impaired insulin secretion in the spontaneous diabetes rats. Tohoku J. Exp. Med., 137, 453-459.
14. KOSAKA, K., KUZUYA, T. & HAGURA, R. (1994). Insulin secretory response in Japanese type 2 (non-insulin-dependent) diabetic patients. Diabetes Res. Clin. Pract., 24, S101-S110.
15. LIGTENBERG, J.J.M., VENKER, C.E., SLUITER, W.J., REITSMA, W.D. & VAN HAEFTEN, T.W. ( 1997). Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man. Eur. J. Clin. Invest., 27, 685-689.
16. LING, Z.-C., KHAN, A., DELAUNEY, F., DAVANI, B., ÖSTENSON, C.-G., GUSTAFSSON, J.-A., OKRET, S., LANDAU, B.R. & EFENDIC, S. (1998). Increased glucocorticoid sensitivity in islet beta-cells: effects on glucose 6-phosphatase, glucose cycling and insulin release. Diabetologia, 41, 634-639.
17. MATSUMOTO, K., YAMAGUCHI, Y., MIYAKE, S., AKAZAWA, S., YANO, M., TOMINAGA, Y. & UEKI, Y. (1997). Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care, 20, 1562-1568.
18. MILLER, W.L., KRAKE, J.J., VANDER BROOK, M.J. & REINEKE, L.M. (1957). Studies on the absorption, mechanism of action, and excretion of tolbutamide in the rat. Ann. N. Y. Acad. Sci. U.S.A., 71, 118-124.
19. NAKAYAMA, K., MURAKAMI, N., OHTA, M., KATO, K., NOTSU, T., MIZOTA, M., MIKWA, I. & OKUDA, J. (1995). Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats. Eur. J. Pharmacol., 276, 85-91.
20. NIDDAM, R., ANGEL, I., BIDET, S. & LANGER, S.Z. (1990). Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets. J. Pharmacol. Exp. Ther., 254, 883-887.
21. OGAWA, A., JOHNSON, J.H. & OHNEDA, M. (1992). Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. J. Clin. Invest., 90, 497-504.
22. ÖSTENSON, C.G., HJEMDAHL, P. & EFENDIC, S. (1993a). Release of catecholamines is increased but does not contribute to the impaired insulin secretion in the pancreata of diabetic rats. Pancreas, 8, 34-38.
23. ÖSTENSON, C.G., KHAN, A., ADBEL-HALIM, S.M., GUENIFI, A., SUZUKI, K., GOTO, Y. & EFENDIC, S. (1993b). Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rats. Diabetologia, 36, 3-8.
24. ÖSTENSON, C.G., NYLÉN, A., GUTNIAK, M. & EFENDIC, S. (1986). Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect. Diabetologia, 29, 861-867.
25. POLONSKY, K.S., GIVEN, B.D., HIRSCH, L.J., TILLIL, H., SHAPIRO, E.T., BEEBE, C., FRANK, B.H., GALLOWAY, J.A. & CAUTER, E.V. (1988). Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med., 318, 1231-1245.
26. PORTE, D. (1991). β-cells in type II diabetes mellitus. Diabetes, 40, 166-180.
27. PORTHA, B., SERRADAS, P., BAILBE, D., SUZUKI, K., GOTO, Y. & GIROIX, M.-H. (1991). β-cell insensibility to glucose in the GK rats, a spontaneous nonobese model for type II diabetes. Diabetes, 40, 486-491.
28. SETO, Y., FUJITA, H., DAN, K., FUJITA, T. & KATO, R. (1995). Stimulating activity of A-4166 on insulin release in in situ Hamster pancreatic perfusion. Pharmacology, 51, 245-253.
29. SILLS, M.N., OGU, C.C. & MAXA, J. (1997). Prolonged hypoglycemic crisis associated with glyburide. Pharmacotherapy, 17, 1338-1340.
30. TAN, M.H., GRAHAM, C.A., BRADLEY, R.F., GLEASON, R.E. & SOELDNER, J.S. (1977). The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetes. Diabetes, 26, 561-570.
31. TAYLOR, S.I., ACCILI, D. & IMAI, Y. (1994). Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes, 43, 735-740.
32. VAN HAEFTEN, T.W., VENEMAN, T.F., GERICH, J.E. & VAN DER VEEN, E.A. (1991). Influence of gliclazide on glucose-stimulated insulin release in man. Metabolism, 40, 751-755.
33. WARD, W.K., BEARD, J.C., HALTER, J.B., PFEIFER, M.A. & PORTE, D. (1984). Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care, 7, 491-502.
34. ZIMMERMAN, B.R. (1997). Sulfonylureas. Endocrinol. Metab. Clin. North Am., 26, 511-522.